This Week in Nature

In this week's Nature, a team led by University of Queensland researchers reports on the genomic analysis of more than 450 pancreatic ductal adenocarcinomas, revealing a variety of disease subtypes. Through the analysis, the scientists uncovered 32 recurrently mutated genes that aggregate into 10 different pathways. RNA expression profiling was used to define four subtypes, each associated with different histolopathological characteristics and differential survival profiles.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.